Inhibition of Rat Hepatic Lipocyte Activation in Culture by Interferon–γ
The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Abstract
Hepatic lipocytes (perisinusoidal, Ito cells) are the primary matrix–producing cells in liver fibrosis. During liver injury they undergo activation, a process characterized by cell proliferation and increased fibrogenesis. We and others have established a culture model in which in vivo features of lipocyte activation can be mimicked by cells grown on plastic. Additionally, we recently showed that activation is associated with new expression of smooth muscle-specific α–actin both in vivo and in culture. Although interferon–γ is known to inhibit collagen production in some systems, its action as a general modulator of lipocyte activation has not been examined; this issue forms the basis for our study. In culture–activated lipocytes, interferon–γ (1,000 U/ml) significantly inhibited lipocyte proliferation as assessed by [3 H]thymidine incorporation assay and nuclear autoradiography. In time–course studies of activation, it also markedly reduced expression of smooth muscle-specific α–actin and its messenger RNA. In dose–response experiments, maximal inhibitory effects on smooth muscle-specific α–actin mRNA gene expression were achieved with as little as 10 U interferon–γ/ml. Inhibition of cellular activation was reversible; after interferon–γ withdrawal, messenger RNA levels of smooth muscle-specific α–actin returned to untreated control levels. The effect of interferon–γ extended to extracellular matrix gene expression, with reduction of type I collagen, type IV collagen and total fibronectin messenger RNAs to 3%, 24% and 15% of untreated control levels, respectively. In contrast to the marked effects on smooth muscle–specific α–actin and extracellular matrix gene expression, interferon–γ reduced total protein synthesis by only 17.7%. Moreover, maximal doses of interferon–γ had no effect on cell viability as determined by exclusion of propidium iodide. In summary, interferon–γ is a potent inhibitor of lipocyte activation and may prove useful in the treatment of fibrotic liver injury. (Hepatology 1992;16:776-784.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [70]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“guanidinium isothiocyanate by the method of Chomczynski and Sacchi (26); integrity of all samples was documented by visualization of 18s and 28s ribosomal bands after electrophoresis through a 0.”
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324 · cited 1×
“Radiolabeled cRNAs were generated by transcription with SP6 or T7 polymerase with [ ~ l - ~ ~ P l CTP (29).”
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Self-citationRoss, R. (1971) · The Journal of Cell Biology · doi:10.1083/jcb.50.1.172 · Cited by 1,569
Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction
Gabbiani, G., Ryan, G. B., & Majno, G. (1971) · Experientia · doi:10.1007/bf02147594 · Cited by 1,485
Self-citationDarby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859 · cited 1×
“approximately 5% to 10% of total protein synthesis in activated lipocytes (39).”
Self-citationBissell, D. M., Arenson, D. M., Maher, J. J., & Roll, F. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112887 · Cited by 543
Self-citationJohnson, R. J., Iida, H., Alpers, C. E., Majesky, M. W., Schwartz, S. M., Pritzi, P., Gordon, K., & Gown, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115089 · Cited by 460
Research works printed but not linked: 9
- Geerts, 1990, HEPATOLOGY, 13, 1193
- Czaja, 1987, HEPATOLOGY, 7, 1047
- Enzan, 1985, Acta Pathol Jpn, 35, 1301
- Friedman, 1989, Gastroenterology, 96, a598
- Pinzani, 1990, HEPATOLOGY, 12, 920
- Mitchell, 1989, Lab Invest, 60, 643
- Kapanci, 1990, Am J Pathol, 136, 881
- Leslie, 1991, Am J Pathol, 139, 207
- Darby, 1990, Lab Invest, 63, 21
Cited by
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Self-citationHepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
“IFN-c exerts direct antifibrogenic effects in HSCs by suppressing proliferation and a-SMA expression, as well as indirectly through NK cell activation.(29,76) IFN-a down-regulates basal and TGF-b-induced collagen gene transcription in HSCs.”
BackgroundRoles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610
Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesis
Inagaki, Y., & Okazaki, I. (2007) · Gut · doi:10.1136/gut.2005.088690 · Cited by 464
Hinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424
Activation of hepatic stellate cells - a key issue in liver fibrosis
Reeves, H. (2002) · Frontiers in Bioscience · doi:10.2741/reeves · Cited by 423
Kawada, N., Seki, S., Inoue, M., & Kuroki, T. (1998) · Hepatology · doi:10.1002/hep.510270512 · Cited by 397
Fu, Y., Zheng, S., Lin, J., Ryerse, J., & Chen, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039818 · Cited by 394
“Prior studies reported the inhibitory role of IFN- in HSC proliferation in vitro (Rockey et al., 1992; Shen et al., 2002).”
BackgroundTransforming growth factor β and the liver
Bissell, M. D., Roulot, D., & George, J. (2001) · Hepatology · doi:10.1053/jhep.2001.28457 · Cited by 348
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Self-citationThe Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Lim, Y.-S., & Kim, W. R. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.007 · Cited by 316
The hepatic stellate (Ito) cell: its role in human liver disease
Hautekeete, M. L., & Geerts, A. (1997) · Virchows Archiv · doi:10.1007/bf01324802 · Cited by 307
Jeong, W.-I., Park, O., Radaeva, S., & Gao, B. (2006) · Hepatology · doi:10.1002/hep.21419 · Cited by 275
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.
Rockey, D. C., Housset, C. N., & Friedman, S. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116769 · Cited by 268
Self-citationWeiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Jeong, W., Park, O., & Gao, B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.034 · Cited by 247
Effects of Sho–Saiko–To, A Japanese Herbal Medicine, on Hepatic Fibrosis in Rats
Shimizu, I., Ma, Y.-R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., et al. (1999) · Hepatology · doi:10.1002/hep.510290108 · Cited by 236
Signal transduction in hepatic stellate cells
Pinzani, M., Marra, F., & Carloni, V. (1998) · Liver · doi:10.1111/j.1600-0676.1998.tb00120.x · Cited by 232
Niki, T., Rombouts, K., De Bleser, P., De Smet, K., Rogiers, V., Schuppan, D., Yoshida, M., Gabbiani, G., & Geerts, A. (1999) · Hepatology · doi:10.1002/hep.510290328 · Cited by 193
Self-citationAlbanis, E., & Friedman, S. L. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70168-9 · Cited by 183
Self-citationInterferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
Mallat, A., Preaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., & Mavier, P. (1995) · Hepatology · doi:10.1002/hep.1840210418 · Cited by 180
Sakaida, I., Tsuchiya, M., Kawaguchi, K., Kimura, T., Terai, S., & Okita, K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00094-1 · Cited by 176
Ankoma-Sey, V., & Friedman, S. L. (1998) · Liver Growth and Repair · doi:10.1007/978-94-011-4932-7_20 · Cited by 173
Self-citationPathogenesis of Liver Fibrosis
Alcolado, R., Arthur, M. J. P., & Iredale, J. P. (1997) · Clinical Science · doi:10.1042/cs0920103 · Cited by 171
Ikeda, K., Wakahara, T., Wang, Y. Q., Kadoya, H., Kawada, N., & Kaneda, K. (1999) · Hepatology · doi:10.1002/hep.510290640 · Cited by 167
Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease
Rockey, D. C. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.011 · Cited by 163
“ical work with IFN-g in hepatic stellate cells showed that this cytokine inhibited multiple aspects of stellate cell activation.(70,71) These data led to an initial pilot study showing”
ResultSelf-citationNatural killer and natural killer T cells in liver fibrosis
Gao, B., & Radaeva, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.008 · Cited by 158
“Recent evidence suggests that production of IFN-γ also contributes significantly to the anti-fibrotic effect of NK cells by directly inducing HSC apoptosis and cell cycle arrest [23,40] and enhancing NK cell killing of activated HSCs [21] (Fig.”
Cytokine Regulation of Hepatic Stellate Cells in Liver Fibrosis
Tsukamoto, H. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199905000-00021 · Cited by 156
Inagaki, Y., Nemoto, T., Kushida, M., Sheng, Y., Higashi, K., Ikeda, K., Kawada, N., Shirasaki, F., Takehara, K., Sugiyama, K., et al. (2003) · Hepatology · doi:10.1002/hep.1840380415 · Cited by 156
Weng, H., Mertens, P. R., Gressner, A. M., & Dooley, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.014 · Cited by 152
“[37].”
Jeong, W.-I., Park, O., Suh, Y.-G., Byun, J.-S., Park, S.-Y., Choi, E., Kim, J.-K., Ko, H., Wang, H., Miller, A. M., et al. (2011) · Hepatology · doi:10.1002/hep.24190 · Cited by 142
Sho‐saiko‐to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma
Shimizu, I. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02138.x · Cited by 129
Okuno, M., Akita, K., Moriwaki, H., Kawada, N., Ikeda, K., Kaneda, K., Suzuki, Y., & Kojima, S. (2001) · Gastroenterology · doi:10.1053/gast.2001.24832 · Cited by 141
Luo, X.-Y., Takahara, T., Kawai, K., Fujino, M., Sugiyama, T., Tsuneyama, K., Tsukada, K., Nakae, S., Zhong, L., & Li, X.-K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2013 · Cited by 120
“For example, IFN- -deficient mice are more susceptible to liver fibrosis induced by carbon tetrachloride (CCl4) (59), and the antifibrogenic effect of IFN- is believed to be mediated via inhibiting hepatic stellate cell (HSC) activation and TGF- signaling (6, 51, 56, 57, 73).”
BackgroundRegulation of hepatocyte fate by interferon-γ
Horras, C. J., Lamb, C. L., & Mitchell, K. A. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.01.001 · Cited by 119
“For example, treatment of cultured rat HSCs with exogenous IFN-γ was shown to inhibit proliferation and decrease extracellular matrix gene expression [132], and similar results were obtained in vivo [130].”
ResultInhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro
Shimizu, I., Mizobuchi, Y., Yasuda, M., Shiba, M., Ma, Y.-R., Horie, T., Liu, F., & Ito, S. (1999) · Gut · doi:10.1136/gut.44.1.127 · Cited by 120
“as well as on the activation of stellate cells in culture.”
BackgroundNatural killer cells and liver fibrosis
Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118
“NK cell-derived IFN-γ has antifibrotic effects by inducing HSC apoptosis and cell cycle arrest (57, 58).”
BackgroundMolecular basis of hepatic fibrosis
Hui, A. Y., & Friedman, S. L. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005684 · Cited by 118
Self-citationAntifibrotic therapy in chronic liver disease
Rockey, D. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00445-8 · Cited by 120
Self-citationHepatic Fibrosis, Stellate Cells, and Portal Hypertension
Rockey, D. C. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.017 · Cited by 112
Self-citationTiggelman, A. M. B. C., Boers, W., Linthorst, C., Sala, M., & Chamuleau, R. A. F. M. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80010-7 · Cited by 124
The stellate cell system (vitamin A-storing cell system)
Senoo, H., Mezaki, Y., & Fujiwara, M. (2017) · Anatomical Science International · doi:10.1007/s12565-017-0395-9 · Cited by 126
Sakaida, I., Matsumura, Y., Akiyama, S., Hayashi, K., Ishige, A., & Okita, K. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80017-5 · Cited by 109
Sakaida, I., Matsumura, Y., Kubota, M., Kayano, K., Takenaka, K., & Okita, K. (1996) · Hepatology · doi:10.1002/hep.510230416 · Cited by 97
Mononuclear cells in liver fibrosis
Marra, F., Aleffi, S., Galastri, S., & Provenzano, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0169-0 · Cited by 92
“At the cellular level, IFN-γ inhibits HSC proliferation and activation and downregulates the expression of extracellular matrix components by these cells [68].”
BackgroundKayano, K., Sakaida, I., Uchida, K., & Okita, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80161-x · Cited by 81
Weng, H., Wang, B.-E., Jia, J., Wu, W., Xian, J.-Z., Mertens, P. R., Cai, W., & Dooley, S. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00404-0 · Cited by 81
The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis
Mladenić, K., Lenartić, M., Marinović, S., Polić, B., & Wensveen, F. M. (2024) · European Journal of Immunology · doi:10.1002/eji.202149641 · Cited by 98
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
Rockey, D. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.01.005 · Cited by 79
Self-citationHepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
Self-citationHepatic sinusoidal cells in health and disease: update from the 14th International Symposium
Smedsrød, B., Le Couteur, D., Ikejima, K., Jaeschke, H., Kawada, N., Naito, M., Knolle, P., Nagy, L., Senoo, H., Vidal‐Vanaclocha, F., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01979.x · Cited by 78
Strutz, F. M., Heeg, M. H. J., Kochsiek, T., Siemers, G., Zeisberg, M., & Muller, G. A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.10.1535 · Cited by 79
Knittel, T. E., Müller, L. P., Saile, B., & Ramadori, G. P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80151-1 · Cited by 77
Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy
Guido, M., Rugge, M., Chemello, L., Leandro, G., Fattovich, G., Giustina, G., Cassaro, M., & Alberti, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80008-0 · Cited by 80
Knight, B., Akhurst, B., Matthews, V. B., Ruddell, R. G., Ramm, G. A., Abraham, L. J., Olynyk, J. K., & Yeoh, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.015 · Cited by 81
“Previous publications have reported that IFNc is anti-fibrotic in vitro and in vivo [27–30].”
BackgroundInterferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.
Marra, F., Choudhury, G. G., & Abboud, H. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118905 · Cited by 74
Inhibition of markers of hepatic stellate cell activation by the hormone relaxin
Bennett, R. G., Kharbanda, K. K., & Tuma, D. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00403-9 · Cited by 75
Wang, Y. Q., Ikeda, K., Ikebe, T., Hirakawa, K., Sowa, M., Nakatani, K., Kawada, N., & Kaneda, K. (2000) · Hepatology · doi:10.1053/jhep.2000.18658 · Cited by 74
Armendáriz‐Borunda, J., Simkevich, C. P., Roy, N., Raghow, R., Kang, A. H., & Seyer, J. M. (1994) · Biochemical Journal · doi:10.1042/bj3040817 · Cited by 75
Athari, A., Hänecke, K., & Jungermann, K. A. (1994) · Hepatology · doi:10.1002/hep.1840200122 · Cited by 70
Innate immunity and alcoholic liver fibrosis
Jeong, W., & Gao, B. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05274.x · Cited by 71
THE CELL AND MOLECULAR BIOLOGY OF HEPATIC FIBROGENESIS
Rockey, D. C. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70113-6 · Cited by 64
Self-citationMolecular aspects of medicine: from experimental to clinical hepatology
Häussinger, D., Kubitz, R., Reinehr, R., Bode, J. G., & Schliess, F. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.001 · Cited by 68
Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis
Gao, B., Radaeva, S., & Jeong, W.-I. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.173 · Cited by 62
Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection
Muir, A. J., Sylvestre, P. B., & Rockey, D. C. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00689.x · Cited by 62
Self-citationInhibition of Hepatic Fibrogenesis: A Review of Pharmacologic Candidates
Wu, J., & Danielsson, A. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409096827 · Cited by 60
Establishment of an Immortalized Human Hepatic Stellate Cell Line to Develop Antifibrotic Therapies
Shibata, N., Watanabe, T., Okitsu, T., Sakaguchi, M., Takesue, M., Kunieda, T., Omoto, K., Yamamoto, S., Tanaka, N., & Kobayashi, N. (2003) · Cell Transplantation · doi:10.3727/000000003108747064 · Cited by 58
An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver
Mancini, R., Benedetti, A., & Jézéquel, A. M. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00197389 · Cited by 58
“This activation and phenotypic modulation are associated with cell enlargement, loss of lipid droplets, and increased amounts of rough endoplasmic reticulum and thin actin-like filaments ( Rockey et al. 1992 ).”
BackgroundInfluentialNan, J., Park, E., Yang, B.-K., Song, C., Ko, G., & Sohn, D. H. (2001) · Archives of Pharmacal Research · doi:10.1007/bf02975101 · Cited by 57
Effects of long-term administration of interferon α in two models of liver fibrosis in rats
Fort, J., Pilette, C., Veal, N., Oberti, F., Gallois, Y., Douay, O., Rosenbaum, J., & Calès, P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80012-3 · Cited by 57
Mechanisms of Alcoholic Liver Injury
French, S. W. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/801735 · Cited by 56
“Of course, Kupffer cell activation by LPS and ethanol leads to increased secretion of cytokines IL-1, -6 and -8, TGF and the chemokines chemokine cytokine-induced neutrophil chemoattractant, macrophage inflammatory protein (MIP), monocyte chemoattractant protein-1 (MCP-1), platelet-activating factor and insulin-like g…”
InfluentialAnimal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis
Weng, H. L. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i1.42 · Cited by 56
Woo, S. W., Nan, J., Lee, S. H., Park, E., Zhao, Y. Z., & Sohn, D. H. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900404.x · Cited by 56
Shen, H., Zhang, M., Minuk, G. Y., & Gong, Y. (2002) · BMC Cell Biology · doi:10.1186/1471-2121-3-9 · Cited by 53
“Moreover, IFN-γ delays phenotypic trans-differentiation of rat hepatic stellate cells in vitro [ 37 ].”
BackgroundSakaida, I., Uchida, K., Matsumura, Y., & Okita, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80322-x · Cited by 52
Matsumura, Y., Saikaida, I., Uchida, K., Kimura, T., Ishihara, T., & Okita, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80300-5 · Cited by 52
Roth-Eichhorn, S., Eberheim, A., Bode, H., & Gressner, A. M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80191-3 · Cited by 52
Expression of heat-shock protein 47 in mouse liver
Kawada, N., Kuroki, T., Kobayashi, K., Inoue, M., Nakatani, K., Kaneda, K., & Nagata, K. (1996) · Cell and Tissue Research · doi:10.1007/s004410050594 · Cited by 54
“Human recombinant transforming growth factor β (TGF β; Friedman 1990; Gressner and Bachem 1995) and recombinant rat interferon γ (IFN γ ;Rockey et al. 1992) are known to enhance or suppress, respectively, the transformation of stellate cells to myofibloblasts and the production of collagen by the…”
BackgroundPark, P., Nan, J., Park, E., Kang, H., Kim, J., Ko, G., & Sohn, D. H. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.pto870604.x · Cited by 49
Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture
Kawada, N., Ikeda, K., Seki, S., & Kuroki, T. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80260-8 · Cited by 50
Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation
Poníachik, J., Baraona, E., Zhao, J., & Lieber, C. S. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90064-1 · Cited by 44
Modulation of experimental mesangial proliferative nephritis by interferon-γ
Johnson, R. J., Lombardi, D. M., Eng, E., GORDON, K. L., Alpers, C. E., Pritzl, P., Floege, J., Young, B. A., Pippin, J. W., Couser, W. G., et al. (1995) · Kidney International · doi:10.1038/ki.1995.7 · Cited by 42
Self-citationYen, M., Weng, T., Liu, S.-Y., Chai, C., & Lin, C. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.442 · Cited by 42
Developments in the treatment of chronic hepatitis C
Pockros, P. J. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.4.515 · Cited by 41
“5 IFN-gamma and cellular immunotherapy IFN-gamma has activity as an antifibrotic cytokine in murine and human hepatic stellate cells [94], as an immunomodulatory cytokine (Th2 to Th1) [95] and as a potential antiviral compound [96].”
BackgroundWhalen, R., Rockey, D. C., Friedman, S. L., & BOYER, T. D. (1999) · Hepatology · doi:10.1002/hep.510300404 · Cited by 43
Self-citationHepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Self-citationPockros, P. J., Patel, K., O’Brien, C., Tong, M. J., Smith, C. I., Rustgi, V. K., Carithers, R. L., McHutchison, J. G., Olek, E. A., & DeBruin, M. F. (2003) · Hepatology · doi:10.1053/jhep.2003.50242 · Cited by 40
Is Interleukin–10 Antifibrogenic in Chronic Liver Injury?
Tsukamoto, H. (1998) · Hepatology · doi:10.1002/hep.510280635 · Cited by 39
Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum
Mizobuchi, Y., Shimizu, I., Yasuda, M., Hori, H., Shono, M., & Ito, S. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80121-9 · Cited by 39
Hepatic Fibrosis – Therapeutic Strategies
Schuppan, D., Strobel, D. D., & Hahn, E. G. (1998) · Digestion · doi:10.1159/000007494 · Cited by 38
Muriel, P. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80148-6 · Cited by 38
Remission of liver fibrosis by interferon-α2b
Moreno, M. G., & Muriel, P. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00154-r · Cited by 38
Kumar, S., Wang, J., Shanmukhappa, S. K., & Gandhi, C. R. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.021 · Cited by 38
Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review)
Zhang, Y., Wu, Y., Shen, W., Wang, B., & Yuan, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12724 · Cited by 35
“Several studies have revealed that IFN‐γ released from NK cells mediates cell cycle arrest and proliferation inhibition of activated HSCs (41,45,46).”
BackgroundExpression of Cellular Prion Protein in Activated Hepatic Stellate Cells
Ikeda, K., Kawada, N., Wang, Y. Q., Kadoya, H., Nakatani, K., Sato, M., & Kaneda, K. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65683-0 · Cited by 35
Cyclosporin A and FK-506 in inhibition of rat Ito cell activation in vitro.
Ikeda, H., & Fujiwara, K. (1995) · PubMed · Cited by 34
Kawada, N., Kuroki, T., Kobayashi, K., Inoue, M., & Kaneda, K. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02091547 · Cited by 33
NK cells in liver homeostasis and viral hepatitis
Peng, H. C., & Tian, Z. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9407-2 · Cited by 34
Review Article: Cystic Degeneration/Spongiosis Hepatis in Rats
Karbe, E., & Kerlin, R. L. (2002) · Toxicologic Pathology · doi:10.1080/019262302753559551 · Cited by 30
“With regard to contractility, Ito cells in injured liver have been described to undergo myo broblastic transformation (44, 61, 65, 67).”
Background
Metadata
- Authors
- Rockey, D. C., Maher, J. J., Jarnagin, W. R., Gabbiani, G., & Friedman, S. L.
- Affiliations
- San Francisco General Hospital (US)
- University of Geneva (CH)
- Corresponding author
- Rockey, Don C.
- Venue
- Hepatology
- Published
- 1992-09
- Volume
- 16
- Issue
- 3
- Pages
- 776-784
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2124972297
- Cited by
- 179
- References
- 60
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 1 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 8400 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01aa007810-12)
- National Institute on Alcohol Abuse and Alcoholism (AA07810)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32 DK 08680-01, T32DK007573, T32-DK07573, P30DK026743)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- interferon-gamma, hepatic stellate cells, liver fibrosis, extracellular matrix gene expression, type I collagen, type IV collagen, fibronectin, cell proliferation
- MeSH terms
- Actins, Adipose Tissue, Animals, Cell Division, Cells, Cultured, Collagen, Extracellular Matrix, Interferon-gamma, Liver, Male, Muscle, Smooth, Rats, Inbred Strains, RNA, Messenger, Protein Biosynthesis, Gene Expression, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.